Large owner Bank Of America Corp /De/ bought $88,208 worth of shares (3,436 units at $25.67) and sold $79,816 worth of shares (3,178 units at $25.12) (SEC Form 4)

3/28/25 4:11:57 PM ET

$HCA

Hospital/Nursing Management

Health Care

Get the next $HCA alert in real time by email

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BANK OF AMERICA CORP /DE/

(Last)

(First)

(Middle)

BANK OF AMERICA CORPORATE CENTER

100 N. TRYON STREET

(Street)

CHARLOTTE

28255

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/26/2011

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾⁽²⁾⁽³⁾	07/26/2011		P		670	A	$27.97	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/10/2012		S		477	D	$21.9	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/13/2012		P		477	A	$23.2884	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		S		100	D	$26.58	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		P		100	A	$26.58	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		S		100	D	$26.58	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		P		100	A	$26.58	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		S		100	D	$26.59	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		P		100	A	$26.59	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/01/2012		S		148	D	$25.1542	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/02/2012		P		148	A	$24.911	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/03/2012		P		1	A	$26.27	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/07/2012		P		32	A	$29	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/13/2012		P		1	A	$27.78	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/14/2012		S		32	D	$25.17	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/14/2012		S		1	D	$25.1	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/17/2012		S		1	D	$25.16	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/22/2012		S		200	D	$25.4089	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/22/2012		P		200	A	$25.4637	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/08/2012		P		1,580	A	$25.28	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/08/2012		S		80	D	$25.31	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/08/2012		S		1,300	D	$25.3147	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/08/2012		S		100	D	$25.315	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/08/2012		S		100	D	$25.315	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/09/2012		P		2	A	$25.63	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/15/2012		S		2	D	$25.34	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/16/2012		S		25	D	$25.33	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/19/2012		P		25	A	$25.18	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	04/03/2012		S		112	D	$26.83	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	04/03/2012		S		300	D	$26.83	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

1. Name and Address of Reporting Person^*

BANK OF AMERICA CORP /DE/

(Last)

(First)

(Middle)

BANK OF AMERICA CORPORATE CENTER

100 N. TRYON STREET

(Street)

CHARLOTTE

28255

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

BANK OF AMERICA NA

(Last)

(First)

(Middle)

BANK OF AMERICA CORPORATE CENTER

100 NORTH TRYON STREET

(Street)

CHARLOTTE

28255

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

MERRILL LYNCH, PIERCE, FENNER & SMITH INC.

(Last)

(First)

(Middle)

ONE BRYANT PARK

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

Explanation of Responses:

1. This statement is jointly filed by Bank of America Corporation, Merrill Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch"), and Bank of America, N.A. ("BANA") (together, the "Reporting Persons"). Bank of America Corporation holds an indirect interest in the securities listed in this Report by virtue of its 100% ownership of its subsidiaries Merrill Lynch, and BANA. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Securities Exchange Act of 1934 (the "Exchange Act"), or for any other purpose.

2. Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the Exchange Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.

3. Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer.

4. The starting ownership position of the Reporting Persons is not reasonably available to the Reporting Persons and has accordingly been omitted pursuant to Rule 12b-21 under the Exchange Act.

Remarks:

Balance of trades included in attached schedule. (See Exhibit 99.1) Exhibit 99.2 - Joint Filing Agreement

	BANK OF AMERICA CORP /DE/ Andres Ortiz By:Its: Authorized Signatory Andres Ortiz	03/28/2025
	BANK OF AMERICA NA Andres Ortiz By:Its Authorized Signatory Andres Ortiz	03/28/2025
	MERRILL LYNCH, PIERCE, FENNER & SMITH INC. Andres Ortiz By:Its Authorized Signatory Andres Ortiz	03/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $HCA alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$HCA

Date	Price Target	Rating	Analyst
12/17/2024	$380.00	Neutral	Analyst
11/25/2024	$400.00 → $320.00	Equal Weight → Underweight	Wells Fargo
11/22/2024		Outperform → Mkt Perform	Raymond James
10/11/2024	$475.00	Overweight	KeyBanc Capital Markets
9/3/2024	$427.00	Equal-Weight	Morgan Stanley
5/30/2024	$396.00	Outperform	Robert W. Baird
3/6/2024	$356.00	Overweight	Barclays
1/4/2024	$277.00 → $301.00	Outperform → Mkt Perform	Bernstein

More analyst ratings

$HCA
Press Releases

Fastest customizable press release news feed in the world

HCA Healthcare Names Monica Cintado as Senior Vice President of Development
Joseph A. Sowell to retire after more than 15 years of service HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Monica Cintado has been appointed as senior vice president of development, effective immediately. In this role, Cintado will lead HCA Healthcare's enterprise development strategy, overseeing mergers, acquisitions, divestitures and strategic investments. She will also guide market analysis, partnership initiatives and real estate strategies to support HCA Healthcare's long-term growth. "Monica is a highly regarded and experienced healthcare development executive and she has played an instrumental role in the growth of HCA He
4/1/25 8:30:00 AM ET
$HCA
Hospital/Nursing Management
Health Care
HCA Healthcare Announces $1.84 Million HCA Healthcare Foundation Grant to United Way
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation, through its Healthier Tomorrow Fund, will give $1.84 million to Mile High United Way to launch United for Healthy Starts, a national collaboration between four United Ways to help increase access to social, economic and educational support services for families. The effort is led by Mile High United Way in Denver and includes United Way of Metropolitan Dallas, United Way Miami and United Way of Greater Nashville. "It's a privilege to help champion the overall health and well-being of families through United for Healthy Starts," said Joanne Pulles, vice pres
3/25/25 8:30:00 AM ET
$HCA
Hospital/Nursing Management
Health Care
100 HCA Healthcare Hospitals Earn Healthgrades Patient Safety Excellence Award
Named among the nation's top hospitals for exceptional, patient-centered care HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that 100 of its hospitals have been recognized as 2025 Patient Safety Excellence Award recipients by Healthgrades for providing exceptional, patient-centered care. This annual recognition is given to the top 10% of hospitals for their commitment to delivering safe, high-quality care. "Patient safety will always be at the forefront of our priorities," said Dr. Michael Cuffe, executive vice president and chief clinical officer of HCA Healthcare. "I am proud of all of our hospitals and their staff, who continue to str
3/13/25 8:30:00 AM ET
$HCA
Hospital/Nursing Management
Health Care

$HCA
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Analyst resumed coverage on HCA with a new price target
Analyst resumed coverage of HCA with a rating of Neutral and set a new price target of $380.00
12/17/24 8:04:06 AM ET
$HCA
Hospital/Nursing Management
Health Care
HCA downgraded by Wells Fargo with a new price target
Wells Fargo downgraded HCA from Equal Weight to Underweight and set a new price target of $320.00 from $400.00 previously
11/25/24 7:44:35 AM ET
$HCA
Hospital/Nursing Management
Health Care
HCA downgraded by Raymond James
Raymond James downgraded HCA from Outperform to Mkt Perform
11/22/24 7:47:44 AM ET
$HCA
Hospital/Nursing Management
Health Care

$HCA
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Large owner Bank Of America Corp /De/ bought $88,208 worth of shares (3,436 units at $25.67) and sold $79,816 worth of shares (3,178 units at $25.12) (SEC Form 4)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
3/28/25 4:11:57 PM ET
$HCA
Hospital/Nursing Management
Health Care

$HCA
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Large owner Bank Of America Corp /De/ bought $88,208 worth of shares (3,436 units at $25.67) and sold $79,816 worth of shares (3,178 units at $25.12) (SEC Form 4)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
3/28/25 4:11:57 PM ET
$HCA
Hospital/Nursing Management
Health Care
SVP & Controller Wyatt Christopher F. was granted 845 shares and covered exercise/tax liability with 227 shares, increasing direct ownership by 2% to 41,067 units (SEC Form 4)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
2/18/25 7:41:24 PM ET
$HCA
Hospital/Nursing Management
Health Care
SVP & Chief Nurse Executive Mosier Sammie S was granted 845 shares and covered exercise/tax liability with 227 shares, increasing direct ownership by 6% to 11,113 units (SEC Form 4)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
2/18/25 7:40:28 PM ET
$HCA
Hospital/Nursing Management
Health Care

$HCA
SEC Filings

SEC Form DEFA14A filed by HCA Healthcare Inc.
DEFA14A - HCA Healthcare, Inc. (0000860730) (Filer)
3/14/25 4:29:58 PM ET
$HCA
Hospital/Nursing Management
Health Care
SEC Form DEF 14A filed by HCA Healthcare Inc.
DEF 14A - HCA Healthcare, Inc. (0000860730) (Filer)
3/14/25 4:27:15 PM ET
$HCA
Hospital/Nursing Management
Health Care
SEC Form PRE 14A filed by HCA Healthcare Inc.
PRE 14A - HCA Healthcare, Inc. (0000860730) (Filer)
3/4/25 4:18:23 PM ET
$HCA
Hospital/Nursing Management
Health Care

$HCA
Leadership Updates

Live Leadership Updates

HCA Healthcare Announces HCA Healthcare Foundation's Support of Girl Scouts Mental Wellness Patch Programs
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation has helped Girl Scouts of the USA (GSUSA) launch a new series of Mental Wellness Patch Programs to address mental wellness among girls in 4th through 12th grade. This is a result of the HCA Healthcare Foundation's $1.38 million grant to GSUSA, through its Healthier Tomorrow Fund, which was announced last year. "The HCA Healthcare Foundation has a long history of partnering with Girl Scouts nationally and locally. We are proud to deepen our partnership with Girl Scouts on this research-based mental wellness program," said Joanne Pulles, vice president of com
9/19/23 8:30:00 AM ET
$HCA
Hospital/Nursing Management
Health Care
HCA Healthcare Appoints Jyric Sims President of Company's West Florida Division
HCA Healthcare, Inc. (NYSE:HCA) today announced Jyric Sims, Ph.D., will become president of the company's West Florida Division, effective June 12. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420005364/en/Jyric Sims, Ph.D. (Photo: Business Wire) Sims, who currently is CEO of HCA Healthcare's Medical City Plano and Medical City Frisco hospitals, will succeed Ravi Chari, M.D., who recently announced he will retire after 15 years with the company to pursue opportunities in early-stage healthcare companies. A more than 20-year healthcare veteran, Sims has been with HCA Healthcare since 2011. He has served as chief executive
4/20/23 8:30:00 AM ET
$HCA
Hospital/Nursing Management
Health Care
HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Chuck Hall, HCA Healthcare's National Group president, will retire at the end of the year after nearly 36 years with the organization. Currently, Hall is responsible for HCA Healthcare's operations at 96 hospitals across 13 states. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005233/en/HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall (Photo: Business Wire) Over more than three decades, Hall has been influential in many successful initiatives that will benefit the company for years to come, inc
8/17/22 8:30:00 AM ET
$HCA
Hospital/Nursing Management
Health Care

$HCA
Financials

Live finance-specific insights

HCA Healthcare Reports Fourth Quarter 2024 Results and Provides 2025 Guidance
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2024. Key fourth quarter metrics (all percentage changes compare 4Q 2024 to 4Q 2023 unless otherwise noted): Revenues totaled $18.285 billion Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per diluted share (which includes an estimated $0.60 per diluted share unfavorable impact from Hurricanes Helene and Milton) Adjusted EBITDA totaled $3.712 billion Cash flows from operating activities totaled $2.559 billion Same facility admissions increased 3.0 percent and same facility equivalent admissions increased 3.1 percent "
1/24/25 7:30:00 AM ET
$HCA
Hospital/Nursing Management
Health Care
HCA Healthcare, Inc. 4th Quarter 2024 Earnings Conference Call
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 4Q 2024 Earnings Call When: Friday, January 24, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire
1/6/25 6:04:00 PM ET
$HCA
Hospital/Nursing Management
Health Care
HCA Healthcare Reports Third Quarter 2024 Results
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2024. Key third quarter metrics (all percentage changes compare 3Q 2024 to 3Q 2023 unless otherwise noted): Revenues totaled $17.487 billion Net income attributable to HCA Healthcare, Inc. totaled $1.270 billion, or $4.88 per diluted share (which includes an estimated $0.15 per diluted share unfavorable impact from Hurricane Helene) Adjusted EBITDA totaled $3.267 billion Cash flows from operating activities totaled $3.515 billion Same facility admissions increased 4.5 percent and same facility equivalent admissions increased 4.5 percent "Our people recently,
10/25/24 7:30:00 AM ET
$HCA
Hospital/Nursing Management
Health Care

$HCA
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
2/14/24 5:10:03 PM ET
$HCA
Hospital/Nursing Management
Health Care
SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
2/14/24 5:06:57 PM ET
$HCA
Hospital/Nursing Management
Health Care
SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
2/13/24 5:06:27 PM ET
$HCA
Hospital/Nursing Management
Health Care

Large owner Bank Of America Corp /De/ bought $88,208 worth of shares (3,436 units at $25.67) and sold $79,816 worth of shares (3,178 units at $25.12) (SEC Form 4)

Chat with this insight

Recent Analyst Ratings for $HCA

$HCA Press Releases

Fastest customizable press release news feed in the world

HCA Healthcare Names Monica Cintado as Senior Vice President of Development

HCA Healthcare Announces $1.84 Million HCA Healthcare Foundation Grant to United Way

100 HCA Healthcare Hospitals Earn Healthgrades Patient Safety Excellence Award

$HCA Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Analyst resumed coverage on HCA with a new price target

HCA downgraded by Wells Fargo with a new price target

HCA downgraded by Raymond James

$HCA Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.